Akèy › Anplwayè › Glenmark Pharmaceuticals, Inc. USA
Glenmark Pharmaceuticals, Inc. USA: Salè H-1B ak pajon
Glenmark Pharmaceuticals, Inc. USA depoze 18 aplikasyon kondisyon travay pou visa H-1B ak visa ki gen rapò nan ane fiskal 2023–2026; sètifye: 17. Medyèn salè yo ofri a: $125,000.
Èske Glenmark Pharmaceuticals, Inc. USA pajone visa H-1B?
Glenmark Pharmaceuticals, Inc. USA depoze 18 aplikasyon kondisyon travay nan ane fiskal 2023–2026, dènye a soumèt sou Jun 11, 2026. Yon LCA se premye etap yon demann H-1B, konsa anplwayè a pajone oswa prepare pou pajone travayè H-1B; li pa garanti pajon pou okenn travay espesifik. Tcheke lis travay pwòp anplwayè a.
Demands Green Card (PERM) pou Glenmark Pharmaceuticals, Inc. USA: 5 →
Salè pa tit travay
| Tit travay | LCA | Salè medyan |
|---|---|---|
| Validation Specialist | 3 | $107,000 |
| Senior Director “ Quality, North America | 3 | $210,000 |
| Manufacturing, Science & Technology (MSAT) Manager | 2 | $135,794 |
| Sterile Injectable Supervisor | 1 | $105,000 |
| Senior Research Scientist | 1 | $125,000 |
| Site Quality Head | 1 | $315,000 |
| Director Engineering & Projects | 1 | $200,000 |
| Senior Validation Specialist | 1 | $123,058 |
| Director of Quality Assurance | 1 | $192,571 |
| Senior Manager- QC Stability | 1 | $139,616 |
| Senior MSAT Specialist | 1 | $111,662 |
| Associate Manager, Demand Planning | 1 | $99,000 |
| Supervisor, Sterile Injectable Process | 1 | $111,699 |
Aplikasyon pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|---|---|
| FY2023 | 1 | $107,000 |
| FY2024 | 4 | $115,880 |
| FY2025 | 9 | $166,094 |
| FY2026 | 4 | $126,644 |
Nivo salè prevanlan
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Kote travay yo ye
Okipasyon
- Industrial Production Managers7
- Industrial Engineers5
- Chemists3
- Chemical Engineers1
- Architectural and Engineering Managers1
- Logisticians1
Dènye aplikasyon yo
| Tit travay | Salè baz | Kote | Soumèt | Dat kòmansman | Estati |
|---|---|---|---|---|---|
| Supervisor, Sterile Injectable Process | $111,699 Nivo IV | Monroe, NC | Jun 11, 2026 | Nov 13, 2026 | Certifye |
| Associate Manager, Demand Planning | $99,000 Nivo III | Elmwood Park, NJ | May 12, 2026 | Oct 1, 2026 | Certifye |
| Senior Director “ Quality, North America | $210,000 Nivo III | Elmwood Park, NJ | Apr 2, 2026 | Apr 2, 2026 | Certifye |
| Manufacturing, Science & Technology (MSAT) Manager | $141,589 Nivo II | Monroe, NC | Sep 30, 2025 | Mar 8, 2026 | Certifye |
| Senior Director “ Quality, North America | $210,000 Nivo III | Elmwood Park, NJ | Sep 2, 2025 | Oct 1, 2025 | Certifye |
| Senior Director “ Quality, North America | $210,000 Nivo III | Elmwood Park, NJ | Aug 29, 2025 | Oct 2, 2025 | Retire |
| Senior Manager- QC Stability | $139,616 Nivo III | Monroe, NC | Jul 9, 2025 | Oct 31, 2025 | Certifye |
| Senior MSAT Specialist | $111,662 Nivo III | Monroe, NC | Jul 3, 2025 | Nov 14, 2025 | Certifye |
| Validation Specialist | $111,662 Nivo III | Monroe, NC | Jun 26, 2025 | Nov 14, 2025 | Certifye |
| Director of Quality Assurance | $192,571 Nivo III | Mahwah, NJ | May 7, 2025 | Oct 1, 2025 | Certifye |
| Senior Validation Specialist | $123,058 Nivo III | Monroe, NC | Feb 4, 2025 | May 4, 2025 | Certifye |
| Site Quality Head | $315,000 Nivo IV | Monroe, NC | Dec 20, 2024 | Jan 15, 2025 | Certifye, apre retire |
| Director Engineering & Projects | $200,000 Nivo III | Monroe, NC | Dec 18, 2024 | Jan 6, 2025 | Certifye |
| Validation Specialist | $106,759 Nivo III | Monroe, NC | Aug 15, 2024 | Jan 23, 2025 | Certifye |
| Senior Research Scientist | $125,000 Nivo III | Monroe, NC | Mar 18, 2024 | May 27, 2024 | Certifye |
| Manufacturing, Science & Technology (MSAT) Manager | $130,000 Nivo IV | Monroe, NC | Nov 2, 2023 | Nov 27, 2023 | Certifye |
| Sterile Injectable Supervisor | $105,000 Nivo IV | Monroe, NC | Oct 25, 2023 | Nov 13, 2023 | Certifye |
| Validation Specialist | $107,000 Nivo III | Monroe, NC | Oct 20, 2022 | Nov 14, 2022 | Certifye |
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).